| Filed On | Filing |
|---|---|
| 08 Sep 2025 | 15-12G |
| 04 Sep 2025 | SCHEDULE 13G |
| 28 Aug 2025 | SC 13E3/A |
| 28 Aug 2025 | S-8 POS |
| 28 Aug 2025 | S-8 POS |
| 28 Aug 2025 | S-8 POS |
| 28 Aug 2025 | S-8 POS |
| 28 Aug 2025 | POSASR |
| 28 Aug 2025 |
Form 4: Fabbri Beth Amber L., SVP Chief Corp Affairs Officer
Returned 124,670 shares to the issuer |
| 28 Aug 2025 |
Form 4: Mahajan Manmohan, EVP and Global CFO
Returned 414,273 shares to the issuer |
| 28 Aug 2025 |
Form 4: Minnix Lanesha, EVP, Global CLO & Corp. Sec.
Returned 348,093 shares to the issuer |
| 28 Aug 2025 |
Form 4: Wentworth Timothy C, Chief Executive Officer
Returned 1,332,014 shares to the issuer |
| 28 Aug 2025 |
Form 4: Heckman Todd, SVP, Global Controller and CAO
Returned 93,037 shares to the issuer |
| 28 Aug 2025 |
Form 4: Langowksi Mary, EVP, President U.S. Healthcare
Returned 494,295 shares to the issuer |
| 28 Aug 2025 |
Form 4: Burger Elizabeth, EVP, Global Chief HR Officer
Returned 303,875 shares to the issuer |
| 28 Aug 2025 |
Form 4: Brown Tracey D, EVP, Pres., Walgreens Retail
Returned 348,051 shares to the issuer |
| 28 Aug 2025 |
Form 4: Gates Richard P., SVP, Chief Pharmacy Officer
Returned 145,444 shares to the issuer |
| 28 Aug 2025 |
Form 4: Barra Ornella, Chief Operating Officer, Int'l
Returned 2,687,057 shares to the issuer ($30.8M) · Disposed of 940,593 Employee Stock Options (right to buy) (Disposition to Issuer) |
| 28 Aug 2025 |
Form 4: Pessina Stefano, Director
Returned 146,938,623 shares to the issuer ($1.68B) · Disposed of 1,994,010 Employee Stock Options (right to buy) (Disposition to Issuer) |
| 28 Aug 2025 | SCHEDULE 13D/A |
Loading...
